Tele-HS
OtherPatients will be given information on the Tele-HS and given access to take the screening at home or in-office, depending on arm.
NCT Number: NCT02928107
The aim of this project is to develop evidence that can inform hearing health care best practices for adults between the ages of 65-75, and determine what level of involvement by the primary care practitioner (PCP) is required to inform and encourage adults age 65-75 to follow through with routine hearing screening.
This study also aims to evaluate the accuracy of assessment of medical conditions for which the FDA requires physician evaluation and management prior to hearing aid fitting, and determine which medical conditions should require medical evaluation prior to hearing aid fitting.
The results of this study should provide information to implement changes in health care policy to facilitate accessible and affordable hearing health care.
Looking for future studies?
Notify Me65 year–75 year
All sexes
Interventional
Not applicable
University of Michigan, Ann Arbor, Michigan, United States
Age-related hearing loss is the third-most common chronic condition affecting older adults in the US (data from Healthy People 2020 US Dept of Health and Human Services). This study aims to improve the understanding of attitudes, barriers and facilitators needed to improve hearing health care delivery. Two study cohorts of study participants between the ages of 65 - 75 are proposed.
The first cohort of participants include healthy adults being seen by a primary care provider (PCP) for a routine appointment. Each participating primary care practice is assigned to one of three different telephone hearing screening strategies that include progressive levels of PCP time and guidance to complete telephone-based hearing screening. Those who fail a telephone hearing screening go on to a medical referral study and receive (1) diagnostic audiological testing and (2) determination of the reliability and validity of identification of conditions that should require medical referral prior to hearing aid provision (called FDA 'Red Flag' conditions, including conditions such as sudden hearing loss, cerumen impaction, conductive hearing loss, dizziness, external deformity, ear drainage). We will evaluate the proportion of subjects in Groups 1 and 2 who dial the phone number and complete the telephone hearing test at or within two months of their PCP visit, relative to Group 3, and the proportion of subjects in all groups who: a) schedule and b) complete the visit for diagnostic audiological testing, and subsequently, c) complete a plan for appropriate hearing loss intervention, if indicated, within four months of initial hearing screening. Enrollment in this cohort is complete. 955 subjects were screened for eligibility. Of those, 660 patients were enrolled.
The second cohort includes adults who are being seen for a routine appointment for a complaint of hearing loss at one of several participating Ear, Nose, and Throat (ENT) practices in the CHEER network. Information about Red Flag conditions will be obtained from the patient, audiologist, and ENT provider. This information, along with Red Flag data from the PCP Cohort, will be used to evaluate the accuracy of assessment of medical conditions for which the FDA requires physician evaluation and management prior to hearing aid fitting, and determine which medical conditions should require medical evaluation prior to hearing aid fitting. Enrollment in this cohort is ongoing. The anticipated enrollment goal is 500 subjects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Primary Care Cohort:
Inclusion criteria
Exclusion criteria
CHEER Cohort:
Inclusion criteria
Exclusion criteria
Patients will be given information on the Tele-HS and given access to take the screening at home or in-office, depending on arm.
Patients will or will not either receive PCP encouragement to do the Tele-HS.
Time frame: 2 months of PCP appointment (day 1)
The proportion (%) of subjects in Groups 1 and 2 who take the test will be compared to those in Group 3.
Time frame: 1 day (following completion of Red Flag questionnaires by patient, audiologist and medical provider)
Analysis of medical conditions for which the FDA requires physician evaluation prior to hearing aid fitting by comparing red flag assessments from patient, audiologist and ENT provider (CHEER Cohort)
Time frame: 4 months of date of Tele-HS
The proportion (%) of subjects in Groups 1 and 2 who fail the Tele-HS and schedule follow-up testing compared to those in Group 3.
Time frame: 4 months of date of Tele-HS
The proportion (%) of subjects in Groups 1 and 2 who fail the Tele-HS and complete follow-up testing compared to those in Group 3.
Time frame: 4 months of date of Tele-HS
The proportion (%) of subjects in Groups 1 and 2 who fail the Tele-HS, complete follow-up testing, and complete a plan for hearing loss intervention, if applicable, compared to those in Group 3.
Time frame: 1 day, completion of patient, audiologist and provider questionnaires
Analysis to determine what medical conditions should require medical evaluation prior to hearing aid fitting (CHEER Cohort)
Time frame: 1 day
Cost to conduct hearing screening based on costs of educational material, telephone screening test, provider time and clinic space. (Both Cohorts)
Time frame: 2 days
Analysis of attitudes towards hearing loss using the ALHQ questionnaire and focus group discussions
Time frame: 1 day, completion of the Significant Other Hearing Questionnaire (SOS-HEAR)
Evaluation of how attitudes of significant others impact decision making to pursue hearing screening, diagnostic testing, and intervention.
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05219474
Ear Diseases, Hearing Disorders
New York, United States
View Trial DetailsNCT01805167
Ear Diseases, Hearing Disorders
Nice, France
View Trial DetailsNCT05070429
Aging, Ear Diseases
Hagerstown, Maryland, United States
View Trial DetailsNCT07501312
Ear Diseases, Hearing Disorders
Aurora, Illinois, United States
View Trial Details